ADVERTISEMENT



HEALTHCARE

Dubai launches stem cell therapy for joint disease

November 22, 2017

Bioscience Clinic, located in Dubai Healthcare City has launched its latest innovative therapy for treatment of joint disease, becoming the first to use stem cells taken from adipose tissue in a variety of clinical applications.

Its latest therapy was first introduced in Europe by Bioscience Institute in partnership with the University of Rome, a Bioscience Clinic sister company.

"... Continue Reading

No health fee rise to KD 130 prior to 2020 – Affordable family plans eyed

November 22, 2017

Chief Executive Officer of the Health Assurance Hospitals Company — Dhaman, Dr Ahmed Al-Saleh denied rumors circulated on social media alleging health insurance fee will be increased to KD 130 from early next year. Dr Al-Saleh noted it is impossible to increase insurance fee before inaugurating the Dhaman hospitals in 2020.

He"... Continue Reading

Dubai First to Launch Innovative Stem Cell Therapy for Joint Disease

November 21, 2017

Dubai First to Launch Innovative Stem Cell Therapy for Joint Disease

Bioscience Clinic FZ LLC located in Dubai Healthcare City is pleased to launch to its latest innovative therapy for treatment of joint disease. Established since 2012, Bioscience Clinic is Dubai’s first and most advanced clinic to use stem cells taken from adipose tissue in a variety of clinical applications. Its latest therapy"... Continue Reading

Cancer Patients, Survivors, Supporters and Caregivers Undertake UAE's First Relay for Life

November 20, 2017

Cancer Patients, Survivors, Supporters and Caregivers Undertake UAE's First Relay for Life

(AETOS Wire)-- Sharjah, the third largest of the United Arab Emirate’s seven emirates, was the host for the MENA region’s first ever ‘Global Relay for Life,’ (RFL) a 24-hour walkathon that is the biggest fundraising event for cancer in the world. Conducted in conjunction with the American Cancer Society, the event was organised by Friends of"... Continue Reading

Prime Hospital Reiterates Commitment Enhancing Healthcare Sector with Ultrasound-Guided Nerve Blocks

November 20, 2017

Prime Hospital Reiterates Commitment Enhancing Healthcare Sector with Ultrasound-Guided Nerve Blocks

Prime Hospital, one of the UAE’s leading healthcare service providers, has achieved another milestone by applying various innovative Anesthetic Techniques developed to bring pain relief to patients after surgery. This is part of the hospital’s continuous efforts to enhance its care for patients, and contribute to raising the health"... Continue Reading

Health Min. denies rumors on releasing Egyptian products

November 19, 2017

Kuwaiti Health Minsiter Dr. Jamal Al-Harbi denied Saturday recent rumors on the Public Authority for Food and Nutrition (PAFN) releasing imported Egyptian agricultural products without being checked by the supreme committee for food safety.
The ministry will not release these products unless receiving health and pesticide-free"... Continue Reading

Emirates Hospital Reaffirms Commitment to Medical Tourism

November 19, 2017

Emirates Hospital Reaffirms Commitment to Medical Tourism

Emirates Hospital, a leading healthcare facility owned by KBBO Group, has reaffirmed its commitment to providing medical services to tourists, particularly Chinese visitors.

During official visit and meeting with Dr. Jia Xiao Fang, President of China International Health & Medical Tourism Association (CIHMTA), China’s"... Continue Reading

NMC Healthcare to Speak At Milken Institute London Summit on Impact of AI on Healthcare Sector

November 19, 2017

NMC Healthcare to Speak At Milken Institute London Summit on Impact of AI on Healthcare Sector

The growth operation and management (O&A) model in the healthcare sector will enable healthcare providers around the world to offer patients better services, according to the CEO of the region’s leading healthcare groups, NMC Healthcare.

Speaking ahead of his participation on a panel entitled"... Continue Reading

New England Journal of Medicine Publishes Results of Phase III FLAURA Trial in the 1st-Line Treatment of EGFR-mutated Non-small Cell Lung Cancer

November 19, 2017

New England Journal of Medicine Publishes Results of Phase III FLAURA Trial in the 1st-Line Treatment of EGFR-mutated Non-small Cell Lung Cancer

(AETOS Wire)-- AstraZeneca today announced that the New England Journal of Medicine has published the positive results from the Phase III FLAURA trial which provide data for Tagrisso’s (osimertinib) use in the 1st-line treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC).1 The trial showed a statistically significant, clinically meaningful progression-free survival (PFS) advantage for osimertinib, a third-generation, irreversible EGFR tyrosine kinase inhibitor (TKI), compared with current 1st-line EGFR-TKIs, erlotinib or gefitinib.1 Dr. Suresh S. Ramalingam, Principal Investigator of the FLAURA trial, from the Winship Cancer Institute of Emory University, Atlanta, USA, said: “The results of the FLAURA trial may herald a shift in how we treat patients...... Continue Reading

New Data Show Benefit of Tagrisso in Patients with EGFR-mutated Non-small Cell Lung Cancer and Central Nervous System Metastases

November 19, 2017

New Data Show Benefit of Tagrisso in Patients with EGFR-mutated Non-small Cell Lung Cancer and Central Nervous System Metastases

(AETOS Wire) -- AstraZeneca today presented new data from a subgroup analysis of the Phase III FLAURA trial, which explored osimertinib as 1st-line therapy in patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC). Results presented at the ESMO Asia 2017 Congress in Singapore showed"... Continue Reading

Found articles: - Pages